(Q48352892)

10 February 2018

title

Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder. (English)

1 reference

10 February 2018

0 references

1 reference

4

1 reference

10 February 2018

Sophie Erhardt

5

1 reference

10 February 2018

author name string

Sara K Olsson

1

1 reference

10 February 2018

Carl Sellgren

2

1 reference

10 February 2018

Göran Engberg

3

1 reference

10 February 2018

publication date

3 October 2012

1 reference

10 February 2018

published in

Bipolar Disorders

1 reference

10 February 2018

volume

14

1 reference

10 February 2018

issue

7

1 reference

10 February 2018

page(s)

719-726

1 reference

10 February 2018

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia

cites work

1 reference

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

21 January 2018

1 reference

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

21 January 2018

1 reference

Increased cortical kynurenate content in schizophrenia

21 January 2018

1 reference

Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder

21 January 2018

1 reference

Identifying and treating cognitive impairment in bipolar disorder

21 January 2018

1 reference

Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.

21 January 2018

1 reference

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

21 January 2018

1 reference

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

21 January 2018

1 reference

Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons

21 January 2018

1 reference

Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia

21 January 2018

1 reference

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis

21 January 2018

1 reference

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

21 January 2018

1 reference

Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area

21 January 2018

1 reference

Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid

21 January 2018

1 reference

Endogenous kynurenic acid disrupts prepulse inhibition

21 January 2018

1 reference

Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI.

21 January 2018

1 reference

Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia

21 January 2018

1 reference

Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders

21 January 2018

1 reference

Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

21 January 2018

1 reference

L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.

21 January 2018

1 reference

Elevations of endogenous kynurenic acid produce spatial working memory deficits

21 January 2018

1 reference

Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding.

21 January 2018

1 reference

Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis

21 January 2018

1 reference

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

21 January 2018

1 reference

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection

21 January 2018

1 reference

Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder

21 January 2018

1 reference

21 January 2018

1 reference

Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors

21 January 2018

1 reference

Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.

21 January 2018

1 reference

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

21 January 2018

1 reference

Phencyclidine-induced psychosis

21 January 2018

1 reference

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

21 January 2018

1 reference

Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder

21 January 2018

1 reference

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia

21 January 2018

1 reference

Immunocytochemical localization of kynurenine aminotransferase in the rat striatum: a light and electron microscopic study

21 January 2018

1 reference

Characterization of the kynurenine pathway in human neurons

21 January 2018

1 reference

Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice

21 January 2018

1 reference

Induction of the kynurenine pathway by neurotropic influenza A virus infection

21 January 2018

1 reference

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

Molecules in focus: indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder

21 January 2018

1 reference

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

21 January 2018

1 reference

Enhancement of brain kynurenic acid production by anticonvulsants--novel mechanism of antiepileptic activity?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BDI.12009

1 reference

10 February 2018

1 reference

10 February 2018